Rapid and persistent regression of severe new vessels on the disc in proliferative diabetic retinopathy after a single intravitreal injection of pegaptanib

Acta Ophthalmologica

Volumn 87, Issue 6, 2009, Pages 683-684

  Mendrinos, Efstratios ^a   Donati, Guy ^a   Pournaras, Constantin J ^a  

^a Department of Ophthalmology ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN A1C; PEGAPTANIB;

ADULT; ANEMIA; CASE REPORT; DIABETIC RETINOPATHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; LETTER; OPTIC DISK; PRIORITY JOURNAL; RETINA NEOVASCULARIZATION; SINGLE DRUG DOSE; SLIT LAMP; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE;

ADULT; APTAMERS, NUCLEOTIDE; DIABETIC RETINOPATHY; FEMALE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; OPTIC DISK; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 69449084039     PISSN: 1755375X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2008.01391.x     Document Type: Letter

References (12)

1. Adamis AP, Altaweel M, Bressler NM et al. (2006 Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals. Ophthalmology 113 : 23 28.
2. Aiello LP, Avery RL, Arrigg PG et al. (1994 Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331 : 1480 1487.
3. Avery RL, Pearlman J, Pieramici DJ et al. (2006 Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 113 : 363 372.
4. Cunningham ET Jr., Adamis AP, Altaweel M et al. (2005 A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 112 : 1747 1757.
5. Fang X, Sakaguchi H, Gomi F et al. (2008 Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema. Acta Ophthalmol 86 : 800 805.
6. Gragoudas ES, Adamis AP, Cunningham ET Jr., Feinsod M Guyer DR (2004 Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351 : 2805 2816.
7. Jonas JB, Libondi T, von Baltz S Vossmerbaeumer U (2008 Intravitreal bevacizumab for vitreous haemorrhage. Acta Ophthalmol 86 : 585 586.
8. Jorge R, Costa RA, Calucci D, Cintra LP Scott IU (2006 Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study). Retina 26 : 1006 1013.
9. ®) with pars plana vitrectomy. Acta Ophthalmol 86 : 812 813.
10. ®) in proliferative diabetic retinopathy. Acta Ophthalmol 86 : 683 687.
11. Shima C, Sakaguchi H, Gomi F et al. (2008 Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol 86 : 372 376.
12. Soliman W, Vinten M, Sander B, Soliman KA, Yehya S, Rahman MS Larsen M (2008 Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedema. Acta Ophthalmol 86 : 365 371.